U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
Raxorulimogene belzovacirepvec expressed IgGL–T2A-?CTLA4-IgGH
Common Name English
Raxorulimogene belzovacirepvec expressed anti-cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) immunoglobulin G1 ?1-chain fused via a synthetic T2A peptide with human immunoglobulin kappa chain (anti-CTL4 antibody) with the Ig? signal sequence for th
Preferred Name English
Code System Code Type Description
FDA UNII
Z7K8WVV2H3
Created by admin on Wed Apr 02 14:32:00 GMT 2025 , Edited by admin on Wed Apr 02 14:32:00 GMT 2025
PRIMARY
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966